bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026)
bioAffinity Technologies has reported Change in Receivables over the past 5 years, most recently at $143274.0 for Q1 2026.
- Quarterly Change in Receivables rose 181.66% to $143274.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$278508.0 through Mar 2026, down 74.21% year-over-year, with the annual reading at -$597242.0 for FY2025, 282.35% down from the prior year.
- Change in Receivables was $143274.0 for Q1 2026 at bioAffinity Technologies, up from $92972.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $472017.0 in Q2 2024 and troughed at -$541875.0 in Q2 2025.
- The 5-year median for Change in Receivables is $956.0 (2022), against an average of -$25226.2.
- Year-over-year, Change in Receivables tumbled 42949.02% in 2023 and then skyrocketed 57880.48% in 2024.
- A 5-year view of Change in Receivables shows it stood at $559.0 in 2022, then tumbled by 42949.02% to -$239526.0 in 2023, then increased by 21.53% to -$187964.0 in 2024, then surged by 149.46% to $92972.0 in 2025, then soared by 54.1% to $143274.0 in 2026.
- Per Business Quant, the three most recent readings for BIAF's Change in Receivables are $143274.0 (Q1 2026), $92972.0 (Q4 2025), and $27121.0 (Q3 2025).